Chacón BA

Language: Spanish
References: 37
Page: 53-59
PDF size: 289.76 Kb.

ABSTRACT

Nowdays, many pharmacological options revolutions the obstetrician’s world. The cervical ripening and delivery labour induction have taken strength respect in the last century. In many women, the delivery labour start spontaneously an it finishes with the vaginal birth at term or near. Nevertheless, the women need the cervical ripening and delivery labour induction due to obstetrics an medicals complications. This methods have the interesting potential about the maternal and perinatal advantages. The porpouse is to get a vaginal labour and to avoid the caesarean.

REFERENCES

1. American College of Obstetricians and Gynaecologists. “New U.S: Food an Drug Administration Labeling on Cytotec (Misoprostol) Use and Pregnancy”. ACOG Committee Opinion. Vol. 101(283). Mayo 2003: 1049-1050.

2. Baxley EG. “Labor induction: a decade of change”. American Family Physician. Vol. 67 (10). Mayo 2003: 2076,2078,2083-2084.

3. Beigi A, et al. “Cervical ripening with oral Misoprostol at term”. International Journal of Gynecology and Obstetrics. Vol. 83 (3). Diciembre 2003: 251-255.

4. Blanchard, et al. “Misoprostol for Women’s Health: A review”. Obstetrics & Gynecology. Vol. 99 (2). Febrero 2002: 316-327.

5. Chong YS, et al. “Does the route of administration of Misoprostol make a difference? The uterotonic effect and side effects of Misoprostol given by different routes after vaginal delivery” European Journal of Obstetrics & Gynecology and Reproductive Biology. Vol. 113 (2). Abril 15, 2004: 191-198.

6. Culver J, et al. “A randomized trial comparing vaginal Misoprostol versus Foley catheter with concurrent oxytocin for labor induction in nulliparous women”. American Journal of Perinatology. Vol. 21 (3). Abril 2004: 139-146.

7. Dallenbach P, et al. “Oral Misoprostol or vaginal dinoprostone for labor induction: a randomised controlled trial”. American Journal Obstetrics & Gynecology. Vol. 188 (1). Enero 2003: 162-167.

8. Daniel Spiegel E. “For how long should oxytocin be continued during induction of labour?”. BJOG. Vol. 111. Abril 2004: 331-334.

9. De Aquino MM, et al. “Misoprostol versus oxitocina for labor induction in term and post-term”. Sao Paulo Medical Journal. Vol. 121.Mayo 2003: 102-106.

10. Ding DC, et al. “Intravaginal and intracervical Misoprostol for cervical ripening of labor in primiparas ”. International Journal of Gynecology and Obstetrics. Vol. 82 (2). Agosto 2003: 209-211.

11. Elhassan M, et al. “Intravaginal Misoprostol vs. Dinoprostone as cervical ripening and labor-inducing agents” . International Journal of Gynecology and Obstetrics. Vol. 85 (3). Enero 2004: 285-286.

12. Goldberg AB, et al. “Induction of labor:The Misoprostol Controversy”. Journal of Midwifery & Women’s Health.Vol.48(4). Julio/agosto 2003:244-248.

13. Hall R, et al. “Oral versus vaginal Misoprostol for labor induction”. Obstetrics & Gynecology. Vol. 99 (6). Junio 2002: 1044-1048.

14. Herabutya Y, et al. “Induction of labor with vaginal Misoprostol for second trimester termination of pregnancy in the scarred uterus”. International Journal of Gynecology and Obstetrics. Vol. 83 (3). Diciembre 2003: 293-297.

15. Hussaini TK, et al. “Oral Misoprostol vs. intravenous oxytocin for labor induction in women with prelabor rupture of membranes at term”. International Journal of Gynecology and Obstetrics. Vol. 82 (1). Julio 2003: 73-76.

16. Ie Roux PA, et al. “Oral and vaginal Misoprostol compared with dinoprostone for induction of labor: a randomized controlled trial”. Obstetrics & Gynecology. Vol 99 (2). Febrero 2002: 201-205.

17. Joy SD, et al. “ Misoprostol use during the third stage of labor”. International Journal of Gynecology and Obstetrics. Vol. 82 (2). Agosto 2003: 143-152.

18. Khan RU, et al. “Pharmacokinetics and adverse- effect profile of rectally administered Misoprostol in the third stage of labor”. Obstetrics & Gynecology. Vol. 101 (5 pt 1). Mayo 2003: 968-974.

19. Lo JY, et al. “Rupture membranes at term: randomized, double blind trial of oral Misoprostol for labor induction”. Obstetrics & Gynecology. Vol. 101 (4). Abril 2003: 685-689.

20. Lokugamage AU, et al. “Misoprostol and pregnancy: ever increasing indications of effective usage”. Current Opinion Obstetrics & Gynecology. Vol. 15 (6). Diciembre 2003: 513-518.

21. Lumbiganon P, et al. “Side effects of oral Misoprostol during the first 24 hours after administration in the third stage of labour”. BJOG. Vol. 109 (11). Noviembre 2002: 1222-1226.

22. Medical Editors of American Family Physician.“Using Rectal Misoprostol in the third stage of labor”.American Family Physician. Vol.69(2).Enero 15, 2004: 400.

23. Mendilcioglu I, et al. “Successful termination of a cervical pregnancy with Misoprostol” European Journal of Obstetrics & Gynecology and Reproductive Biology. Vol. 106 (1). Enero 2003: 96.

24. Meydanli MM, et al. “Labor induction post-term with 25 micrograms vs. 50 micrograms of intravaginal Misoprostol ”. International Journal of Gynecology and Obstetrics. Vol. 81 (3). Junio 2003: 249-255.

25. Mutlu M, et al. “Prediction of adverse outcome associated with vaginal Misoprostol for labor induction”. Obstetrical and Gynecological Survey. Vol. 59 (4). Abril 2004: 247-248.

26. Okman T, et al. “Rectal Misoprostol vs. vaginal Misoprostol for first trimester termination of pregnancy”. International Journal of Gynecology and Obstetrics. Vol. 85 (1). Abril 2004: 64-65.

27. Ozsoy M, D. “Induction of labor with 50 and 100 mcg of Misoprostol: comparison of maternal and fetal outcomes”. European Journal of Obstetrics & Gynecology and Reproductive Biology. Vol. 113 (1). Marzo 15, 2004: 41-44.

28. Ramsey PS, et al. “Comparative efficacy and cost of the prostaglandin analogs dinoprostone and Misoprostol as labor preinduction agents”. American Journal Obstetrics & Gynecology. Vol.188(2). Febrero 2003: 560-565.

29. Rockhead C, et al. “A comparison of two methods of labor induction with vaginal Misoprostol ”International Journal of Gynecology and Obstetrics. Vol. 80 (3). Marzo 2003: 271-277.

30. Rozenberg P, et al “Induction of labour with a viable infant: a randomised clinical trial comparing intravaginal Misoprostol and intravaginal dinoprostone”. BJOG. Vol. 108 (12). Diciembre 2002: 1255-1262.

31. Sánchez-Ramos L, et al. “The effect of tablet moistening on labor induction with intravaginal Misoprostol: A randomized trial”. Obstetrics & Gynecology. Vol. 99 (6). Junio 2002: 1080-1084.

32. Shetty A, et al. “Oral Misoprostol (100 mcg) versus vaginal Misoprostol (25 mcg) in term labor induction: a randomized comparison”. Acta Obstetricia et Gynecologica Scandinavica. Vol. 82 (12). Diciembre 2003: 1103-1106.

33. Thomas A, et al. “Uterine rupture in a primigravida with Misoprostol used for induction of labour”. BJOG. Vol. 110 (2). Febrero 2003: 217-218.

34. Urban R, et al. “Misoprostol and Dinoprostone therapy for labor induction: a Doppler comparison of uterine and fetal hemodynamic effects ”. European Journal of Obstetrics & Gynecology and Reproductive Biology. Vol. 106 (1). Enero 10, 2003: 20-24.

35. Van GN, et al. “A randomised trial comparing low dose vaginal Misoprostol and dinoprostone for labour induction”. BJOG. Vol. 111 (1). Enero 2004: 42-49.

36. Williams MC, et al. “Dose variation that is associated with approximated one- quarter tablet doses of Misoprostol”. American Journal Obstetrics & Gynecology. Vol. 187 (3). Setiembre 2002: 615-619.

37. Wright JM, Newton W. “Is rectal Misoprostol as effective as oxytocin in preventing postpartum hemorrhage? ”. Journal Family Practice. Vol. 52 (4). Abril 2003. 281-282.